The Science of Childhood Cancer is an interactive, weekly lecture series designed to engage the scientific community on key questions in pediatric cancer research. The Fall 2024 lecture season begins August 8 and runs through November 14. You may register below for future seasons of the series, hosted by the St. Jude Comprehensive Cancer Center.
Invited speakers are leading experts across the spectrum of basic, translational, clinical and population science. The Rising Stars of Cancer Research lecture in the 15-week series will feature thematically related talks by two early- to mid-career investigators conducting exciting and innovative work in the field.
Lectures occur each Thursday from 12 pm – 1 pm Central time / 1 pm – 2 pm Eastern time and are often followed by an extended Q&A session. Available recordings will be posted the week following the live event.
Hosts
-
- Executive Vice President
- Director, Comprehensive Cancer Center
-
- Deputy Director, Comprehensive Cancer Center
- Co-Leader, Hematological Malignancies Program
- Medical Director, St. Jude Biorepository
Upcoming lectures
August 8, 2024
Recent results from translational and clinical studies in childhood acute lymphoblastic leukemia in the Princess Máxima Center
Rob Pieters, MD PhD MSc
Chief Medical Officer
Princess Máxima Center for Pediatric Oncology
August 15, 2024
Decoding CAR T-cell phenotype using combinatorial signaling motif libraries and machine learning
Kyle Daniels, PhD
Assistant Professor of Genetics
Stanford University School of Medicine
Targeting transcription factors to augment CAR T cell fitness
Evan Weber, PhD
Assistant Professor of Pediatrics
University of Pennsylvania
Children’s Hospital of Philadelphia
August 22, 2024
Engineered cell therapy for pediatric cancer
Stephen Gottschalk, MD
Chair, Department of Bone Marrow Transplantation and Cellular Therapy
Co-Director, Center of Excellence for Pediatric Immuno-Oncology
St. Jude Children's Research Hospital
August 29, 2024
Wild type and mutant p53 functions
Guillermina Lozano, PhD
Chair, Department of Genetics
The University of Texas MD Anderson Cancer Center
September 5, 2024
Chromatin and cancer: from mechanisms to emerging therapies
Charles WM Roberts, MD PhD
Member, St. Jude Faculty
Executive Vice President
Director, Comprehensive Cancer Center
September 12, 2024
Diagnosis of leukemia: from phenotype to genotype to artificial intelligence
Torsten Haferlach, MD PhD
CEO
Munich Leukemia Laboratory
September 19, 2024
Modeling curative combination therapies
Adam Palmer, PhD
Assistant Professor, Computational Medicine Program
Department of Pharmacology
Lineberger Comprehensive Cancer Center
University of North Carolina, Chapel Hill
September 26, 2024
Cancer genes beyond chromosomes
Howard Chang, MD PhD
Professor, Stanford University School of Medicine
Howard Hughes Medical Institute
October 3, 2024
RNA biology in MDS and modeling myelodysplasia
Stephanie Halene, MD
Chief, Section of Hematology
Department of Internal Medicine and Yale Cancer Center
Yale University School of Medicine
October 10, 2024
Oncogenesis in pediatric glioma, moving beyond the genome
Cynthia Hawkins, MD, PhD
Neuropathologist, The Hospital for Sick Children
Professor, University of Toronto
October 17, 2024
Developmental heterogeneity in rhabdomyosarcoma
Mark Hatley, MD, PhD
Associate Member
Director Division of Molecular Oncology
Department of Oncology
October 24, 2024
The Childhood Cancer Data Initiative: An update
Greg Reaman, MD
Scientific Director, Childhood Cancer Data Initiative
National Cancer Institute
October 31, 2024
Addressing the challenges of HPV vaccination in young cancer survivors
Wendy Landier, PhD, CRNP
Professor, Pediatric Hematology/Oncology
University of Alabama at Birmingham
November 7, 2024
Decoding transcriptional regulation
Alexander Stark, PhD
Senior Group Leader
Research Institute of Molecular Pathology
Vienna, Austria
November 14, 2024
Developmental programs contribute to chemoresistance in pediatric solid tumors
Michael Dyer, PhD
Chair, Developmental Neurobiology Department
Co-Leader, Developmental Biology & Solid Tumor Program
Richard C. Shadyac Endowed Chair in Pediatric Cancer Research
Investigator, Howard Hughes Medical Institute
Comprehensive Cancer Center
St. Jude is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children.
